Quick Search

 

 


 

 

Result Summary for AZLF3002

Result Summary
Protocol ID: AZLF3002
Clinical Study ID: AZLF 3002
Official Title: Multicentre, open-label, pilot study to evaluate the efficacy and safety of a triple therapy combining AZT/3TC/ABC as a combined tablet of Trizivir, in HIV-infected patients with an undetectable viral load after quadruple therapy (COM, ABC, EFV) during CNAF 3008 study (La Francilienne).
Phase: Phase 3
Study Indications or Diseases:
  • Infection, Human Immunodeficiency Virus I
Generic Name: abacavir/lamivudine/zidovudine
Trade/Product Name: trizivir;trizivir
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.